Ashley Volaric
Assistant Professor
PRONOUNS she/her/hers
Larner College of Medicine
111 Colchester Ave
Main Campus, East Pavilion, Level 1, 114A
Burlington, VT 05405
United States
- Fellowship, Cytopathology, Stanford University, Stanford, CA
- Fellowship, Hematopathology, Stanford University, Stanford, CA
- Residency, Anatomic and Clinical Pathology, University of Virginia, Charlottesville, VA
- M.D., University of Virginia School of Medicine, Charlottesville, VA
- B.Sc., University of Virginia, Charlottesville, VA
Department of Pathology and Laboratory Medicine
University of Vermont Cancer Center
Areas of expertise
Hematopathology
BIO
Ashley K. Volaric, MD, is an Assistant Professor on the Clinical Scholar pathway in the Department of Pathology and Laboratory Medicine at the Robert Larner, MD College of Medicine at the University of Vermont (UVM) and an attending hematopathologist at the University of Vermont Medical Center. She is board-certified in Anatomic and Clinical Pathology with subspecialty certification in Hematopathology and Cytopathology. Dr. Volaric serves as a Research Project Leader for the NIH-funded Translational Global Infectious Diseases Research (TGIR) Center of Biomedical Research Excellence (COBRE) and is an Associate Member of the Emerging Leader Corps for the UVM Cancer Center. She is also the founder of the Global Hematopathology Group (GHG), a collaborative network of academic hematopathologists dedicated to advancing research, education, and capacity-building initiatives in low-resource global settings. As a physician–scientist, Dr. Volaric’s clinical expertise in hematolymphoid diagnostics directly informs her translational research program, which focuses on the oncogenic role of Epstein–Barr virus (EBV) in B-cell lymphomas across diverse patient populations, integrating molecular pathology, epigenetics, and global health perspectives while actively educating medical graduate trainees.
Regionally and nationally recognized for her scholarship in hematopathology and viral oncogenesis, Dr. Volaric has established a focused and externally funded research program investigating the diagnostic, prognostic, and biologic role of EBV in B‑cell lymphomas, including within the immunodeficient setting. Her work has resulted in peer-reviewed original research and invited review articles in leading pathology journals and has been supported by the NIH, UVM Cancer Center, and Department of Pathology funding, including her role as a Research Project Leader on the NIH-funded COBRE award. Dr. Volaric is actively engaged in national and international professional service, serving on scientific review panels and editorial boards and contributing to professional organizations focused on hematopathology, cytopathology, and global health. A committed educator and mentor, she provides hands-on and didactic instruction to medical students, residents, fellows, and graduate trainees. She has developed sustainable, bi-directional global pathology collaborations that integrate education, capacity-building, and research to advance equitable diagnostic care for patients worldwide.
As a physician–scientist and clinical scholar, Dr. Volaric is committed to advancing precision diagnostics and translational research in hematopathology, with a particular focus on improving outcomes for patients with EBV-associated B‑cell lymphomas across both local and global settings. Her current initiatives integrate molecular pathology, epigenetic profiling, spatial biomarker technologies, and radiologic–pathologic correlation to refine diagnostic accuracy and uncover biologic determinants of disease pathogenesis, particularly in immunodeficiency-associated B-cell lymphomas. Through interdisciplinary collaboration within the UVM Cancer Center and sustained partnerships in Southern Africa, she is building a research program that emphasizes equitable access to high-quality pathology services, workforce development, and bi-directional education. Dr. Volaric’s work reflects a deep commitment to the missions of the Larner College of Medicine and the University of Vermont Medical Center by uniting innovative research, excellence and equitability in clinical care, and mentorship of the next generation of physician–scientists.
Publications
Dr. Volaric's Publications on PubMed
Awards and Achievements
- 2020 Resident Citizenship Award, UVA Department of Pathology, Elected by peers based on defined as reliability, accountability and commitment to helping co-residents and the residency as a whole.
- 2018 Outstanding Qualitative Research Poster Award, UVA Medical Alumni Association Annual Meeting
- 2015 - 2016 Gold Humanism Honor Society (GHHS), UVA School of Medicine, Student Member- GHHS recognizes individuals who have both a humanistic approach to patient care and can serve as leaders for these practices in the medical field. Membership requires both peer and faculty recommendation as well as demonstration of patient care excellence.
- 2011 Alpha Chi Sigma Chemistry Award, University of Virginia, Award Recipient - Acknowledged by Chemistry faculty for demonstration of undergraduate chemistry excellence.
Bio
Ashley K. Volaric, MD, is an Assistant Professor on the Clinical Scholar pathway in the Department of Pathology and Laboratory Medicine at the Robert Larner, MD College of Medicine at the University of Vermont (UVM) and an attending hematopathologist at the University of Vermont Medical Center. She is board-certified in Anatomic and Clinical Pathology with subspecialty certification in Hematopathology and Cytopathology. Dr. Volaric serves as a Research Project Leader for the NIH-funded Translational Global Infectious Diseases Research (TGIR) Center of Biomedical Research Excellence (COBRE) and is an Associate Member of the Emerging Leader Corps for the UVM Cancer Center. She is also the founder of the Global Hematopathology Group (GHG), a collaborative network of academic hematopathologists dedicated to advancing research, education, and capacity-building initiatives in low-resource global settings. As a physician–scientist, Dr. Volaric’s clinical expertise in hematolymphoid diagnostics directly informs her translational research program, which focuses on the oncogenic role of Epstein–Barr virus (EBV) in B-cell lymphomas across diverse patient populations, integrating molecular pathology, epigenetics, and global health perspectives while actively educating medical graduate trainees.
Regionally and nationally recognized for her scholarship in hematopathology and viral oncogenesis, Dr. Volaric has established a focused and externally funded research program investigating the diagnostic, prognostic, and biologic role of EBV in B‑cell lymphomas, including within the immunodeficient setting. Her work has resulted in peer-reviewed original research and invited review articles in leading pathology journals and has been supported by the NIH, UVM Cancer Center, and Department of Pathology funding, including her role as a Research Project Leader on the NIH-funded COBRE award. Dr. Volaric is actively engaged in national and international professional service, serving on scientific review panels and editorial boards and contributing to professional organizations focused on hematopathology, cytopathology, and global health. A committed educator and mentor, she provides hands-on and didactic instruction to medical students, residents, fellows, and graduate trainees. She has developed sustainable, bi-directional global pathology collaborations that integrate education, capacity-building, and research to advance equitable diagnostic care for patients worldwide.
As a physician–scientist and clinical scholar, Dr. Volaric is committed to advancing precision diagnostics and translational research in hematopathology, with a particular focus on improving outcomes for patients with EBV-associated B‑cell lymphomas across both local and global settings. Her current initiatives integrate molecular pathology, epigenetic profiling, spatial biomarker technologies, and radiologic–pathologic correlation to refine diagnostic accuracy and uncover biologic determinants of disease pathogenesis, particularly in immunodeficiency-associated B-cell lymphomas. Through interdisciplinary collaboration within the UVM Cancer Center and sustained partnerships in Southern Africa, she is building a research program that emphasizes equitable access to high-quality pathology services, workforce development, and bi-directional education. Dr. Volaric’s work reflects a deep commitment to the missions of the Larner College of Medicine and the University of Vermont Medical Center by uniting innovative research, excellence and equitability in clinical care, and mentorship of the next generation of physician–scientists.
Publications
Awards and Achievements
- 2020 Resident Citizenship Award, UVA Department of Pathology, Elected by peers based on defined as reliability, accountability and commitment to helping co-residents and the residency as a whole.
- 2018 Outstanding Qualitative Research Poster Award, UVA Medical Alumni Association Annual Meeting
- 2015 - 2016 Gold Humanism Honor Society (GHHS), UVA School of Medicine, Student Member- GHHS recognizes individuals who have both a humanistic approach to patient care and can serve as leaders for these practices in the medical field. Membership requires both peer and faculty recommendation as well as demonstration of patient care excellence.
- 2011 Alpha Chi Sigma Chemistry Award, University of Virginia, Award Recipient - Acknowledged by Chemistry faculty for demonstration of undergraduate chemistry excellence.